BioAtla, Inc. Common Stock (BCAB) is a publicly traded Healthcare sector company. As of September 29, 2026, BCAB trades at $1.74 with a market cap of $2.89M and a P/E ratio of -0.40. BCAB moved -42.99% today. Year to date, BCAB is -93.89%; over the trailing twelve months it is -91.74%. Its 52-week range spans $1.51 to $71.50. Rallies surfaces BCAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks BCAB insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.74 |
| Market Cap | $2.89M |
| P/E Ratio | -0.40 |
| EPS | $-4.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $71.50 |
| 52-Week Low | $1.51 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $8.50M |
| Net Income | $-31.45M |
| Gross Margin | 0.00% |
BCAB analyst coverage data. Average price target: $0.00.